Brief: Evelo Biosciences Q2 EPS USD -3.78
14/08/2023 14:31
Aug 14 (Reuters) - Evelo Biosciences Q2 operating income USD -19.574 million. * Q2 operating expenses USD 19.574 million * Q2 EPS USD -3.78 * Q2 pretax profit USD -20.87 million * Q2 net income USD -21.103 million
Recent news on Evelo Biosciences
See all newsU.S. RESEARCH ROUNDUP- Evelo Biosciences, Nkarta, O'Reilly Automotive
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
Evelo Bio slumps after skin disease drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Nvidia, Westlake, North American steel companies
U.S. STOCKS ON THE MOVE-TMC, PayPal, TOMI